Tsinsue Chen, MD
Tsinsue Chen, MD, is a neurosurgeon in the Department of Neurosurgery at Barrow Neurological Institute.
Dr. Chen’s expertise includes deep brain stimulation for the treatment of movement disorders; functional neurosurgery; and the surgical treatment of trigeminal neuralgia, hemifacial spasm, and other facial pain syndromes. She also treats brain tumors, spinal tumors, spinal stenosis, and cervical and lumbar disc disease. Dr. Chen is a member of the American Association for Stereotactic and Functional Neurosurgery, the American Association of Neurological Surgeons, the Arizona Neurosurgical Society, the Congress of Neurological Surgeons, and the World Society for Stereotactic and Functional Neurosurgery.
Dr. Chen earned her medical degree from the University of California-San Diego School of Medicine. She completed her neurosurgical residency at Barrow Neurological Institute, and she received her fellowship training in stereotactic and functional neurosurgery at Barrow and at the National Hospital for Neurology and Neurosurgery in Queen Square, London, England.
Dr. Chen’s research interests focus on advanced techniques as well as quality-of-life improvement and outcomes after deep brain stimulation for movement disorders and other emerging indications.
To request an appointment with Dr. Chen, please call (480) 917-5600.
Jie Wu, MD, PhD
Dr. Jie Wu joined Barrow in 1998 as a principal investigator and as Director of Epilepsy Research. Since 2000 he has overseen several research projects on the physiology, pharmacology, and pathophysiology of neuronal nicotinic acetylcholine receptors (nAChR) using both heterologously expressed and natural nAChRs. Dr. Wu also investigates the epileptogenesis of human gelastic seizures using surgically resected human hypothalamic hamartoma tissue from patients with gelastic seizures. He is a leader in the study of the epileptogenic mechanisms underlying human hypothalamic hamartomas. He has used his experience as an electrophysiologist to make significant contributions to the study of nAChRs.
Since 2000, Dr. Wu’s laboratory has been published in more than 100 peer-reviewed papers such as Nature Chemistry (1), PNAS (1), Molecular Psychiatry (1), Annals Neurology (2), Trend in Pharmacology Science (1), Journal of Neuroscience (6), among others. His research papers have been cited 2,763 times (as of April 29, 2016), and he carries an h-index of 30 and an i10-index of 79. The research programs that constitute the Wu Laboratory have been funded by the NIH and other foundations including NIHR01 (5), NIHR21 (3), NIHU19 (2), Philip Morris External Research grant (2), Arizona Biomedical Research Commission (3). Dr. Wu has also contributed to six book chapters and owns four United States utility patents. Dr. Wu is an adjunct professor at Arizona State University and a research professor at the University of Arizona Medical College in Phoenix. Dr. Wu is editor in chief of the journal Chemistry and Pharmacology: Open Access and associate editor of Acta Pharmacologica Sinica. He also serves on the editorial board for several scientific journals.
Dr. Wu pursued postdoctoral training at both the University of New Mexico and Tohoku University School of Medicine in Japan. He received his PhD from Sun Yet-Sen University of Medical Sciences and his MD from Xuzhou Medical College, both in China.